RNXT CIK: 1574094

RenovoRx, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
0.04
FY25:
0.80
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.67
FY22:
−9.95
FY23:
−11.4
FY24:
−11.0
FY25:
−12.5
(positive)
Change from FY21 to FY24
millions USD
FY21:
−5.54
FY22:
−9.94
FY23:
−13.1
FY24:
−12.7
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.32
FY22:
−9.89
FY23:
−10.2
FY24:
−8.75
FY25:
−11.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.32
FY22:
−9.89
FY23:
−10.2
FY24:
−8.81
FY25:
−11.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data